As shown in Figs. 11, 12, 13 and 14, DRD2 and DRD4 receptors were significantly higher than other DRDs in treated (free BRC and MWCNTs-BRC Nf) lung cancer cell lines compared to untreated groups. This evidence concerns the gene DRD2 and lung cancer.